Cite

HARVARD Citation

    Pleyer, C. et al. (2018). Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia. Leukemia & lymphoma. 59 (12), pp. 2792-2800. [Online]. 
  
Back to record